CLL expert Dr. Jeff Sharman, on location at the ASH (American Society of Hematology) 2015 meeting, Dr. Jeff Sharman, shares the latest in CLL research news. Listen as Dr. Sharman explains in detail the expected outcomes of the RESONATE Phase III trial, as well as the ongoing research on ABT-199. When asked if he is hopeful, Dr. Sharman responds with an enthusiastic, Oh, gosh, yeah!…The statistics aren’t real anymore.CLL patients are living much more normal lives
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo